57S-14024-88078
2 vaccinations
3 coded responses
4 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 193 / PA
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-23
Registered in v-safe
-
2021-04-23
Survey response — day 14, dose 1MedDRA: Dyspnoea, Eye irritation, Headache, Inflammation, Musculoskeletal chest pain, Pain, Self-medication — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Still experiencing shortness of breath and respiratory problems and pain in chest wall from inflammation. Horrendous headaches that last for 20 hours out of 24 hours. Not relieved with OTC Tylenol, Advil, or aspirin. Terrible pain and burning in eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — day 21, dose 1MedDRA: Fatigue, Headache, Respiratory disorder, Vision blurred — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Continuing to have respiratory issues and required another prednisone prescription. Extreme fatigue and blurred vision extreme Headaches still persist.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-05
-
2021-05-17
Dose 2 — Pfizer-BioNTech
-
2021-07-06
Survey response — 3 months, dose 1MedDRA: Alopecia, Office visit, Respiratory disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Respiratory problems and massive hair loss. · Healthcare visit (other): Primary care physician and a specialistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Report sent to call center — 3 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-08
-
2021-08-06
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-05-17 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 14, dose 1
Symptoms: Still experiencing shortness of breath and respiratory problems and pain in chest wall from inflammation. Horrendous headaches that last for 20 hours out of 24 hours. Not relieved with OTC Tylenol, Advil, or aspirin. Terrible pain and burning in eyes cut off by CDC
Release 8 — day 21, dose 1
Symptoms: Continuing to have respiratory issues and required another prednisone prescription. Extreme fatigue and blurred vision extreme Headaches still persist.
Release 9 — 3 months, dose 1
Symptoms: Respiratory problems and massive hair loss.
Healthcare visit (other): Primary care physician and a specialist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Alopecia | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Eye irritation | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Musculoskeletal chest pain | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Respiratory disorder | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release